Summary & Overview
CPT 0369T: Duodenal Mucosal Resurfacing, Endoscopic
CPT code 0369T is designated for duodenal mucosal resurfacing performed endoscopically, a novel procedure in gastroenterology aimed at treating certain gastrointestinal disorders. This code is significant as it reflects advancements in minimally invasive techniques, offering patients alternatives to conventional surgery. The procedure is most commonly performed in outpatient hospital settings, aligning with broader healthcare trends toward ambulatory care.
Key payers covered in this analysis include Blue Cross Blue Shield and Cigna Health, both of which play a major role in national reimbursement policies for gastroenterology services. Readers will gain insight into clinical benchmarks, policy updates, and billing practices associated with 0369T. The publication also provides context on related procedures, common modifiers, and associated diagnoses, helping stakeholders understand the evolving landscape of endoscopic treatments. This summary is intended for healthcare administrators, billing professionals, and clinicians seeking clarity on coding, coverage, and clinical applications for duodenal mucosal resurfacing.
CPT Code Overview
CPT code 0369T represents duodenal mucosal resurfacing, endoscopic, a procedure performed within the field of gastroenterology. This minimally invasive technique is typically conducted in an outpatient hospital setting (Place of Service 22). The procedure involves the endoscopic treatment of the duodenal mucosa, which may be indicated for various gastrointestinal conditions. As an outpatient service, it is designed to offer patients a less invasive alternative to traditional surgical interventions, supporting quicker recovery times and reduced hospital stays.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult presenting to a gastroenterology clinic with chronic duodenal mucosal disease, such as persistent gastritis or gastroduodenitis, that has not responded to standard medical therapy. The patient may experience symptoms like abdominal pain, dyspepsia, or reflux. After evaluation, including diagnostic endoscopy, the provider determines that duodenal mucosal resurfacing via endoscopic technique is appropriate. The procedure is performed in an outpatient hospital setting, where the physician uses specialized endoscopic equipment to ablate and resurface the duodenal mucosa, aiming to improve mucosal health and reduce symptoms. Post-procedure, the patient is monitored and discharged the same day, with follow-up scheduled to assess clinical response and healing.
Coding Specifications
-
Modifier
52(Reduced Services): Used when the duodenal mucosal resurfacing procedure is partially completed or less than the full service is provided, such as when clinical circumstances require a limited intervention. -
Modifier
53(Discontinued Procedure): Applied when the procedure is started but discontinued due to patient safety concerns or unforeseen circumstances, before completion.
| Provider Taxonomy Code | Specialty Name |
|---|---|
207RG0100X | Gastroenterology Physician |
207RI0008X | Hepatology Physician |
207R00000X | Internal Medicine Physician |
These taxonomies represent the specialties typically performing or supervising duodenal mucosal resurfacing procedures.
Related Diagnoses
-
K31.89- Other diseases of stomach and duodenum- Relevant for patients with less common or unspecified duodenal conditions that may benefit from mucosal resurfacing.
-
K31.9- Disease of stomach and duodenum, unspecified- Used when the exact nature of the duodenal disease is unclear but intervention is warranted.
-
K29.70- Gastritis, unspecified, without bleeding- Indicates chronic gastritis, a common indication for duodenal mucosal resurfacing when refractory to medical therapy.
-
K29.90- Gastroduodenitis, unspecified, without bleeding- Applies to patients with inflammation of both the stomach and duodenum, suitable for resurfacing procedures.
-
K21.9- Gastro-esophageal reflux disease without esophagitis- May be present in patients undergoing duodenal mucosal resurfacing, especially if symptoms overlap or contribute to duodenal pathology.
Related CPT Codes
-
43239- Esophagogastroduodenoscopy, with biopsy- Used for diagnostic evaluation and tissue sampling prior to or in conjunction with duodenal mucosal resurfacing.
-
43249- Esophagogastroduodenoscopy, with balloon dilation- May be performed if duodenal strictures are present and require dilation before resurfacing.
-
43235- Esophagogastroduodenoscopy, diagnostic- Commonly used for initial assessment of the duodenum to determine eligibility for resurfacing.
-
43270- Endoscopic mucosal resection- Related as an alternative or adjunct procedure for removing abnormal mucosal tissue, though it is distinct from resurfacing.
These codes are often used together in the clinical workflow for diagnosis, preparation, or as alternatives depending on patient needs.
National Reimbursement Benchmarks
Nationally, commercial mean rates for CPT code 0369T are highest for Blue Cross Blue Shield, Cigna, and BUCA, with BUCA and Cigna both averaging around $40.53–$40.55. Medicare rates are not available in the input for comparison.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, is tightest for Blue Cross Blue Shield, where all percentiles are $25.00, indicating no variation. Cigna and BUCA both show a slightly wider range, with a $1.20 difference between the 75th and 25th percentiles ($40.80 - $39.60 for Cigna, $40.80 - $39.50 for BUCA).
The table and chart below present the full breakdown of national mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.